Precocious puberty--perspectives on diagnosis and management.

Area of Science:

• Pediatrics
• Endocrinology
• Reproductive Health

Background:

• Precocious puberty is defined by early onset of secondary sexual characteristics, with evolving age definitions due to secular trends.
• Distinguishing between central (gonadotropin-dependent, GDPP) and peripheral (gonadotropin-independent, GIPP) forms is critical for diagnosis and management.
• Benign conditions like premature thelarche and pubarche can mimic precocious puberty, necessitating a systematic diagnostic approach.

Purpose of the Study:

• To outline the diagnostic criteria and management strategies for precocious puberty.
• To differentiate between gonadotropin-dependent and independent forms of precocious puberty.
• To review current treatment options, particularly the efficacy of GnRH analogs.

Main Methods:

• Systematic clinical evaluation including detailed history and physical examination.
• Biochemical screening using basal LH levels and GnRH stimulation tests to diagnose GDPP.
• High-resolution brain MRI to identify central nervous system abnormalities.

Main Results:

• Basal LH levels below 0.1 IU/L suggest a prepubertal stage; GnRH analog stimulation confirms GDPP.
• GnRH analogs (GnRHa) are the current gold standard treatment for GDPP, demonstrating reversible effects on sexual maturation.
• Treatment for GIPP remains less satisfactory, highlighting an area for further research.

Conclusions:

• Accurate diagnosis of precocious puberty relies on a combination of clinical assessment and specific hormonal tests.
• GnRH analogs offer an effective and reversible treatment for central precocious puberty in both boys and girls.
• Further research is needed to develop effective treatments for peripheral forms of precocious puberty.